Risk Factor Management in Atrial Fibrillation

Atrial fibrillation (AF) is the most common clinical arrhythmia and is associated with increased morbidity and mortality. There is growing evidence that numerous cardiovascular diseases and risk factors are associated with incident AF and that lone AF is rare. Beyond oral anticoagulant therapy, rate...

Full description

Saved in:
Bibliographic Details
Published inArrhythmia & electrophysiology review Vol. 7; no. 2; pp. 118 - 127
Main Authors Brandes, Axel, Smit, Marcelle D, Nguyen, Bao Oanh, Rienstra, Michiel, Van Gelder, Isabelle C
Format Journal Article
LanguageEnglish
Published England Radcliffe Medical Education Ltd 01.06.2018
Radcliffe Cardiology
Subjects
Cardiac arrhythmia
Cardiovascular disease
Clinical Review: Arrhythmias
Disease prevention
Heart failure
Hypertension
Integrated approach
Ischemia
Mortality
Patients
Risk factors
Stroke
Womens health
risk factors
integrated management
lifestyle modification
Atrial fibrillation
prevention
Online AccessGet full text

Cover

More Information
Summary:Atrial fibrillation (AF) is the most common clinical arrhythmia and is associated with increased morbidity and mortality. There is growing evidence that numerous cardiovascular diseases and risk factors are associated with incident AF and that lone AF is rare. Beyond oral anticoagulant therapy, rate and rhythm control, therapy targeting risk factors and underlying conditions is an emerging AF management strategy that warrants better implementation in clinical practice. This review describes current evidence regarding the association between known modifiable risk factors and underlying conditions and the development and progression of AF. It discusses evidence for the early management of underlying conditions to improve AF outcomes. It also provides perspective on the implementation of tailored AF management in daily clinical practice.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Disclosure: The authors have no conflicts of interest to declare.
ISSN:2050-3369
2050-3377
DOI:10.15420/aer.2018.18.2